LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Linezolid In Sodium Chloride 0.9% In Plastic Container, and what generic alternatives are available?
Linezolid In Sodium Chloride 0.9% In Plastic Container is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is linezolid. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the linezolid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Linezolid In Sodium Chloride 0.9% In Plastic Container
A generic version of LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER was approved as linezolid by HIKMA on June 3rd, 2015.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
- What are the global sales for LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
Summary for LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 146 |
| DailyMed Link: | LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Helmholtz Zentrum Munchen | Phase 2 |
| Janssen, LP | Phase 2 |
| TB Alliance | Phase 2 |
See all LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER clinical trials
Pharmacology for LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
| Drug Class | Oxazolidinone Antibacterial |
US Patents and Regulatory Information for LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | linezolid | SOLUTION;INTRAVENOUS | 206473-001 | Jun 18, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
